Drug interactions
Ado-trastuzumab + Ifosfamide
Severity: Moderate
Ado-trastuzumab and Ifosfamide: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Both agents can damage the heart: ado-trastuzumab emtansine can reduce left ventricular ejection fraction, and ifosfamide has been associated with cardiotoxicity including arrhythmias and heart failure.
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to see why Ado-trastuzumab and Ifosfamide interact, what to do about it, and the sources.
- Mechanism of action
- Clinical management
- Evidence level
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Ado-trastuzumab
Other interactions of Ifosfamide
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
